Selected research
Industry Research
Memantine Hydrochloride Tablets Industry Research Report 2026
Market perspective
The global Memantine Hydrochloride Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Memantine Hydrochloride Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Memantine Hydrochloride Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Memantine Hydrochloride Tablets include Teva Pharmaceuticals USA, Sun Pharma, United Laboratories, Upsher-Smith, Taj Pharma India Limited, Sharon Bio-medicine Limited, Psycogen Captab, Kabir Lifesciences and Consern Pharma Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Memantine Hydrochloride Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Memantine Hydrochloride Tablets Market by Company
Teva Pharmaceuticals USA
Sun Pharma
United Laboratories
Upsher-Smith
Taj Pharma India Limited
Sharon Bio-medicine Limited
Psycogen Captab
Kabir Lifesciences
Consern Pharma Limited
Aripolis Biotech Pvt. Ltd.
Ajanta Pharma Ltd.
Actiza Pharmaceutical Pvt. Ltd.
Memantine Hydrochloride Tablets Segment by Type
Immediate-Release Tablets
Extended-Release Tablets
Memantine Hydrochloride Tablets Segment by Application
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Memantine Hydrochloride Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Memantine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Memantine Hydrochloride Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Memantine Hydrochloride Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Memantine Hydrochloride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immediate-Release Tablets
- Extended-Release Tablets
Applications
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Companies covered
- Teva Pharmaceuticals USA
- Sun Pharma
- United Laboratories
- Upsher-Smith
- Taj Pharma India Limited
- Sharon Bio-medicine Limited
- Psycogen Captab
- Kabir Lifesciences
- Consern Pharma Limited
- Aripolis Biotech Pvt. Ltd.
- Ajanta Pharma Ltd.
- Actiza Pharmaceutical Pvt. Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Memantine Hydrochloride Tablets Market Size (2021-2032)
- 2.2.2 Global Memantine Hydrochloride Tablets Sales (2021-2032)
- 2.2.3 Global Memantine Hydrochloride Tablets Market Average Price (2021-2032)
- 2.3 Memantine Hydrochloride Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Immediate-Release Tablets
- 2.3.3 Extended-Release Tablets
- 2.4 Memantine Hydrochloride Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacy
- 2.4.3 Hospital Pharmacy
- 2.4.4 Online Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Memantine Hydrochloride Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Memantine Hydrochloride Tablets Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Memantine Hydrochloride Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Memantine Hydrochloride Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Memantine Hydrochloride Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Memantine Hydrochloride Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Memantine Hydrochloride Tablets, Product Type & Application
- 3.8 Global Manufacturers of Memantine Hydrochloride Tablets, Established Date
- 3.9 Global Memantine Hydrochloride Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceuticals USA
- 4.1.1 Teva Pharmaceuticals USA Company Information
- 4.1.2 Teva Pharmaceuticals USA Business Overview
- 4.1.3 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Product Portfolio
- 4.1.5 Teva Pharmaceuticals USA Recent Developments
- 4.2 Sun Pharma
- 4.2.1 Sun Pharma Company Information
- 4.2.2 Sun Pharma Business Overview
- 4.2.3 Sun Pharma Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharma Memantine Hydrochloride Tablets Product Portfolio
- 4.2.5 Sun Pharma Recent Developments
- 4.3 United Laboratories
- 4.3.1 United Laboratories Company Information
- 4.3.2 United Laboratories Business Overview
- 4.3.3 United Laboratories Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 United Laboratories Memantine Hydrochloride Tablets Product Portfolio
- 4.3.5 United Laboratories Recent Developments
- 4.4 Upsher-Smith
- 4.4.1 Upsher-Smith Company Information
- 4.4.2 Upsher-Smith Business Overview
- 4.4.3 Upsher-Smith Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Upsher-Smith Memantine Hydrochloride Tablets Product Portfolio
- 4.4.5 Upsher-Smith Recent Developments
- 4.5 Taj Pharma India Limited
- 4.5.1 Taj Pharma India Limited Company Information
- 4.5.2 Taj Pharma India Limited Business Overview
- 4.5.3 Taj Pharma India Limited Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taj Pharma India Limited Memantine Hydrochloride Tablets Product Portfolio
- 4.5.5 Taj Pharma India Limited Recent Developments
- 4.6 Sharon Bio-medicine Limited
- 4.6.1 Sharon Bio-medicine Limited Company Information
- 4.6.2 Sharon Bio-medicine Limited Business Overview
- 4.6.3 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Product Portfolio
- 4.6.5 Sharon Bio-medicine Limited Recent Developments
- 4.7 Psycogen Captab
- 4.7.1 Psycogen Captab Company Information
- 4.7.2 Psycogen Captab Business Overview
- 4.7.3 Psycogen Captab Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Psycogen Captab Memantine Hydrochloride Tablets Product Portfolio
- 4.7.5 Psycogen Captab Recent Developments
- 4.8 Kabir Lifesciences
- 4.8.1 Kabir Lifesciences Company Information
- 4.8.2 Kabir Lifesciences Business Overview
- 4.8.3 Kabir Lifesciences Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Kabir Lifesciences Memantine Hydrochloride Tablets Product Portfolio
- 4.8.5 Kabir Lifesciences Recent Developments
- 4.9 Consern Pharma Limited
- 4.9.1 Consern Pharma Limited Company Information
- 4.9.2 Consern Pharma Limited Business Overview
- 4.9.3 Consern Pharma Limited Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Consern Pharma Limited Memantine Hydrochloride Tablets Product Portfolio
- 4.9.5 Consern Pharma Limited Recent Developments
- 4.10 Aripolis Biotech Pvt. Ltd.
- 4.10.1 Aripolis Biotech Pvt. Ltd. Company Information
- 4.10.2 Aripolis Biotech Pvt. Ltd. Business Overview
- 4.10.3 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 4.10.5 Aripolis Biotech Pvt. Ltd. Recent Developments
- 4.11 Ajanta Pharma Ltd.
- 4.11.1 Ajanta Pharma Ltd. Company Information
- 4.11.2 Ajanta Pharma Ltd. Business Overview
- 4.11.3 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 4.11.5 Ajanta Pharma Ltd. Recent Developments
- 4.12 Actiza Pharmaceutical Pvt. Ltd.
- 4.12.1 Actiza Pharmaceutical Pvt. Ltd. Company Information
- 4.12.2 Actiza Pharmaceutical Pvt. Ltd. Business Overview
- 4.12.3 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 4.12.5 Actiza Pharmaceutical Pvt. Ltd. Recent Developments
5 Global Memantine Hydrochloride Tablets Market Scenario by Region
- 5.1 Global Memantine Hydrochloride Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Memantine Hydrochloride Tablets Sales by Region: 2021-2032
- 5.2.1 Global Memantine Hydrochloride Tablets Sales by Region: 2021-2026
- 5.2.2 Global Memantine Hydrochloride Tablets Sales by Region: 2027-2032
- 5.3 Global Memantine Hydrochloride Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Memantine Hydrochloride Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Memantine Hydrochloride Tablets Revenue by Region: 2027-2032
- 5.4 North America Memantine Hydrochloride Tablets Market Facts & Figures by Country
- 5.4.1 North America Memantine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.4.3 North America Memantine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Memantine Hydrochloride Tablets Market Facts & Figures by Country
- 5.5.1 Europe Memantine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Memantine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Memantine Hydrochloride Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Memantine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Memantine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Memantine Hydrochloride Tablets Market Facts & Figures by Country
- 5.7.1 South America Memantine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.7.3 South America Memantine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Memantine Hydrochloride Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Memantine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Memantine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Memantine Hydrochloride Tablets Sales by Type (2021-2032)
- 6.1.1 Global Memantine Hydrochloride Tablets Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Memantine Hydrochloride Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Memantine Hydrochloride Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Memantine Hydrochloride Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Memantine Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Memantine Hydrochloride Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Memantine Hydrochloride Tablets Sales by Application (2021-2032)
- 7.1.1 Global Memantine Hydrochloride Tablets Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Memantine Hydrochloride Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Memantine Hydrochloride Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Memantine Hydrochloride Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Memantine Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Memantine Hydrochloride Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Memantine Hydrochloride Tablets Value Chain Analysis
- 8.1.1 Memantine Hydrochloride Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Memantine Hydrochloride Tablets Production Mode & Process
- 8.2 Memantine Hydrochloride Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Memantine Hydrochloride Tablets Distributors
- 8.2.3 Memantine Hydrochloride Tablets Customers
9 Global Memantine Hydrochloride Tablets Analyzing Market Dynamics
- 9.1 Memantine Hydrochloride Tablets Industry Trends
- 9.2 Memantine Hydrochloride Tablets Industry Drivers
- 9.3 Memantine Hydrochloride Tablets Industry Opportunities and Challenges
- 9.4 Memantine Hydrochloride Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst